Developing consensus on tobacco control and research.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Preventive Medicine

• Publication date

  2007-12-01

• Fields of study

  Medicine, Political Science

• Identifiers
  DOI 10.1016/J.AMEPRE.2007.09.012PMID 18021904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tobacco policy in the United States: Lessons for the obesity epidemic

  2020cited by this paper
• Smoking cessation for the secondary prevention of coronary heart disease.

  2012cited by this paper
• Ending the tobacco problem.

  2008cited by this paper
• Case–Control Studies

  2008cited by this paper
• The impact of tobacco control programs on adult smoking.

  2008cited by this paper
• A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report.

  2008cited by this paper
• Treating Tobacco Use and Dependence

  2008cited by this paper
• A Dictionary of Epidemiology

  2008cited by this paper
• Quitlines a tool for research and dissemination of evidence-based cessation practices.

  2007cited by this paper
• The Effect of Nicotine Replacement Therapy Advertising on Youth Smoking

  2007cited by this paper
• Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco

  2007cited by this paper
• Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.

  2007cited by this paper
• Cardiovascular toxicity with highly active antiretroviral therapy

  2007cited by this paper
• Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking.

  2007cited by this paper
• Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment

  2007cited by this paper
• Smoking cessation a critical component of medical management in chronic disease populations.

  2007cited by this paper
• CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.

  2007cited by this paper
• Policy interventions and surveillance as strategies to prevent tobacco use in adolescents and young adults.

  2007cited by this paper
• Text and graphic warnings on cigarette packages: findings from the international tobacco control four country study.

  2007cited by this paper
• The California Tobacco Control Program’s effect on adult smokers: (1) Smoking cessation

  2007cited by this paper
• Epidemiologic perspectives on smokeless tobacco marketing and population harm.

  2007cited by this paper
• Changing smokeless tobacco products new tobacco-delivery systems.

  2007cited by this paper
• Increasing reach of quitline services in a US state with comprehensive tobacco treatment

  2007cited by this paper
• Use of smokeless tobacco is a risk factor for cigarette smoking.

  2007cited by this paper
• “Deviance proneness” and adolescent smoking 1980 versus 2001: Has there been a “hardening” of adolescent smoking?☆

  2007cited by this paper
• Are smokers only using cigarettes? Exploring current polytobacco use among an adult population.

  2007cited by this paper
• Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

  2007cited by this paper
• How to prevent 100 million deaths from tobacco.

  2007cited by this paper
• The tobacco epidemic in the United States.

  2007cited by this paper
• A comparative study of sociocultural factors and young adults' smoking in two Midwestern communities.

  2007cited by this paper
• Exposure to Movie Smoking: Its Relation to Smoking Initiation Among US Adolescents

  2007cited by this paper
• Nicotine interventions with comorbid populations.

  2007cited by this paper
• Ending the tobacco problem : a blueprint for the nation

  2007cited by this paper
• Patterns of Global Tobacco Use in Young People and Implications for Future Chronic Disease Burden in Adults

  2007cited by this paper
• Smokeless tobacco brand switching: a means to reduce toxicant exposure?

  2007cited by this paper
• Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses—United States, 1997–2001

  2007cited by this paper
• The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial.

  2007cited by this paper
• Regulating advertisements: the case of smoking cessation products

  2007cited by this paper
• Increasing the demand for and use of effective smoking-cessation treatments reaping the full health benefits of tobacco-control science and policy gains--in our lifetime.

  2007cited by this paper
• Changes in characteristics of New Zealand Quitline callers between 2001 and 2005.

  2007cited by this paper
• Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.

  2007cited by this paper
• Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge

  2007cited by this paper
• The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline

  2007cited by this paper
• Smokers' preferences for medicinal nicotine vs smokeless tobacco.

  2007cited by this paper
• Genetics and smoking cessation improving outcomes in smokers at risk.

  2007cited by this paper
• Longitudinal patterns of youth access to cigarettes and smoking progression: Minnesota Adolescent Community Cohort (MACC) study (2000-2003).

  2007cited by this paper
• Health system changes to facilitate the delivery of tobacco-dependence treatment.

  2007cited by this paper
• Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.

  2007cited by this paper
• Interventions for smoking cessation in hospitalised patients.

  2007cited by this paper
• Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.

  2007cited by this paper
• CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.

  2007cited by this paper
• Provider feedback to improve 5A's tobacco cessation in primary care: a cluster randomized clinical trial.

  2007cited by this paper
• The impact of retail cigarette marketing practices on youth smoking uptake.

  2007cited by this paper
• The California Tobacco Control Program’s effect on adult smokers: (2) Daily cigarette consumption levels

  2007cited by this paper
• Snus--what should the public-health response be?

  2007cited by this paper
• Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.

  2007cited by this paper
• Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.

  2007cited by this paper
• Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study.

  2007cited by this paper
• Cigarette smoking among adults--United States, 2006.

  2007cited by this paper
• Tobacco industry marketing, population-based tobacco control, and smoking behavior.

  2007cited by this paper
• Smokeless tobacco and some tobacco-specific N-nitrosamines.

  2007cited by this paper
• Receptivity to tobacco advertising and promotions among young adolescents as a predictor of established smoking in young adulthood.

  2007cited by this paper
• Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.

  2007cited by this paper
• Characteristics of smokers reached and recruited to an internet smoking cessation trial: a case of denominators.

  2006cited by this paper
• Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial.

  2006cited by this paper
• Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy

  2006cited by this paper
• Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation

  2006cited by this paper
• An experimental study of effects on schoolchildren of exposure to point-of-sale cigarette advertising and pack displays.

  2006cited by this paper
• Cigarettes and oral snuff use in Sweden: Prevalence and transitions.

  2006cited by this paper
• Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study.

  2006cited by this paper
• The genetics of nicotine dependence

  2006cited by this paper
• Role of snus in initiation and cessation of tobacco smoking in Sweden

  2006cited by this paper
• A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS

  2006cited by this paper
• Tobacco Promotion and the Initiation of Tobacco Use: Assessing the Evidence for Causality

  2006cited by this paper
• NIH State-of-the-Science Conference Statement on Tobacco Use: Prevention, Cessation, and Control.

  2006cited by this paper
• CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation

  2006cited by this paper
• Tobacco harm reduction: an alternative cessation strategy for inveterate smokers

  2006cited by this paper
• Levels of toxins in oral tobacco products in the UK

  2006cited by this paper
• Public health implications of smokeless tobacco use as a harm reduction strategy.

  2006cited by this paper
• Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study.

  2006cited by this paper
• Contribution of Swedish moist snuff to the metabolic syndrome: A wolf in sheep's clothing?

  2006cited by this paper
• Symbiotic relationship of pharmacogenetics and drugs of abuse

  2006cited by this paper
• Complementing random-digit-dial telephone surveys with other approaches to collecting sensitive data.

  2006cited by this paper
• Smoking Relapse during the First Year after Treatment for Early-Stage Non–Small-Cell Lung Cancer

  2006cited by this paper
• Addressing Tobacco in Managed Care: Results of the 2003 Survey

  2006cited by this paper
• Cigarette smoking and interest in quitting in methadone maintenance patients.

  2006cited by this paper
• Lack of Association of 5-HTTLPR Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial

  2006cited by this paper
• Promoting smoking cessation in the healthcare environment: 10 years later.

  2006cited by this paper
• Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs.

  2006cited by this paper
• Successes and failures of the teachable moment

  2006cited by this paper
• Impact of smoking cessation aids and mass media among recent quitters.

  2006cited by this paper
• Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials

  2006cited by this paper
• Evaluating the effectiveness of proactive telephone counselling for smoking cessation in a randomized controlled trial.

  2006cited by this paper
• Priorities among effective clinical preventive services: results of a systematic review and analysis.

  2006cited by this paper
• Integrated Tobacco Cessation Counseling in a Diabetes Self-management Training Program

  2006cited by this paper
• Smokeless Tobacco Use and Risk of Stillbirth: A Cohort Study in Mumbai, India

  2006cited by this paper
• Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence

  2006cited by this paper
• Avoiding "truth": tobacco industry promotion of life skills training.

  2006cited by this paper
• The internet and the industrial revolution in smoking cessation counselling.

  2006cited by this paper
• Efficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease: a systematic review and meta-analysis

  2006cited by this paper

• Engaging People in Tobacco Prevention and Cessation: Reflecting Back Over 20 Years Since the Master Settlement Agreement.

  2020cites this paper
• Transforming preventive medicine science, practice, education, and policy: looking back at the last 20 years of the American Journal of Preventive Medicine.

  2013cites this paper
• Improving adherence to web-based cessation programs: a randomized controlled trial study protocol

  2013cites this paper
• Cost-effectiveness of internet and telephone treatment for smoking cessation: an economic evaluation of The iQUITT Study

  2012cites this paper
• Efficiency and Cost-Effectiveness of Recruitment Methods for Male Latino Smokers

  2011cites this paper
• Increasing tobacco cessation in America: A consumer demand perspective.

  2010cites this paper
• Boosting population quits through evidence-based cessation treatment and policy.

  2010cites this paper
• Linking Tobacco Control Policies and Practices to Early Cancer Endpoints: Surveillance as an Agent for Change

  2008cites this paper